Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,855
Closed -$234K 96
2025
Q3
$234K Sell
2,855
-412
-13% -$35.7K 0.03% 87
2025
Q2
$298K Sell
3,267
-105
-3% -$9.39K 0.05% 76
2025
Q1
$309K Sell
3,372
-1,236
-27% -$108K 0.05% 72
2024
Q4
$392K Sell
4,608
-900
-16% -$79K 0.07% 67
2024
Q3
$482K Sell
5,508
-529
-9% -$44.5K 0.09% 60
2024
Q2
$476K Sell
6,037
-812
-12% -$66.7K 0.09% 58
2024
Q1
$619K Sell
6,849
-217
-3% -$19.8K 0.12% 50
2023
Q4
$621K Sell
7,066
-192
-3% -$16K 0.13% 49
2023
Q3
$613K Sell
7,258
-292
-4% -$26.4K 0.14% 52
2023
Q2
$746K Sell
7,550
-840
-10% -$79K 0.17% 49
2023
Q1
$806K Sell
8,390
-794
-9% -$73.5K 0.2% 49
2022
Q4
$835K Sell
9,184
-905
-9% -$77K 0.21% 50
2022
Q3
$802K Sell
10,089
-222
-2% -$18.8K 0.2% 58
2022
Q2
$859K Sell
10,311
-489
-5% -$40.3K 0.21% 67
2022
Q1
$888K Sell
10,800
-3,758
-26% -$294K 0.2% 74
2021
Q4
$1.09M Sell
14,558
-118
-0.8% -$8.86K 0.26% 55
2021
Q3
$1.11M Sell
14,676
-185
-1% -$14.3K 0.26% 65
2021
Q2
$1.15M Sell
14,861
-474
-3% -$36.6K 0.28% 65
2021
Q1
$1.08M Sell
15,335
-2,290
-13% -$173K 0.27% 65
2020
Q4
$1.25M Sell
17,625
-7,107
-29% -$446K 0.35% 53
2020
Q3
$1.42M Sell
24,732
-2,341
-9% -$140K 0.47% 50
2020
Q2
$1.65M Buy
+27,073
New +$1.67M 0.58% 42

Other funds holding DOX

Human Investing's DOX Position: Q4 2025 in Review

Human Investing sold out of Amdocs (DOX) in Q4 2025, closing a stake of 2,855 shares — an estimated $234K sold.

Human Investing first reported a position in DOX in Q2 2020 and held it in 22 quarters. The position peaked at $1.65M in Q2 2020. 492 funds tracked by Wall St. Rank hold DOX as of Q4 2025.

  • Human Investing reported no remaining Amdocs position as of Q4 2025 after selling out during the quarter.
  • Human Investing sold 2,855 Amdocs shares in Q4 2025, an estimated $234K.
  • Human Investing first reported a position in Amdocs in Q2 2020 and held it in 22 quarters.
  • Human Investing's Amdocs position peaked at $1.65M in Q2 2020.
  • 492 funds tracked by Wall St. Rank held Amdocs as of Q4 2025.

Based on Human Investing's 13F filing for Q4 2025, filed 27 Jan 2026.